See more : Coromandel Engineering Company Limited (COROENGG.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Össur hf. (OSSFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Össur hf., a leading company in the Medical – Devices industry within the Healthcare sector.
- IsoEnergy Ltd. (ISO.V) Income Statement Analysis – Financial Results
- Tristate Holdings Limited (0458.HK) Income Statement Analysis – Financial Results
- Grupo Hotelero Santa Fe, S.A.B. de C.V. (HOTEL.MX) Income Statement Analysis – Financial Results
- Qingdao Tianneng Heavy Industries Co.,Ltd (300569.SZ) Income Statement Analysis – Financial Results
- Cellivery Therapeutics, Inc. (268600.KQ) Income Statement Analysis – Financial Results
Össur hf. (OSSFF)
About Össur hf.
Össur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers prosthetics products, including artificial limbs and related products for amputees; and lower and upper limb prosthetic components, including feet, knees, hands, fingers, liners, and other components. The company also provides bracing and supports products, such as supporting devices for spinal, knee, hip, foot, ankle, and hands that are primarily used to support joints and other body parts for therapeutic and preventative purposes; and injury solutions to enhance the healing process of bone and soft tissue injuries. It serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers. The company sells its products through its direct sales networks and distributors. Össur hf. was founded in 1971 and is headquartered in Reykjavik, Iceland. Össur hf. is a subsidiary of William Demant Invest A/S.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 785.68M | 718.65M | 718.67M | 629.50M | 686.26M | 612.88M | 567.82M | 519.57M | 483.03M | 509.36M | 436.27M |
| Cost of Revenue | 300.11M | 310.71M | 297.60M | 268.94M | 274.43M | 240.05M | 226.42M | 204.17M | 179.93M | 186.23M | 166.34M |
| Gross Profit | 485.57M | 407.94M | 421.07M | 360.56M | 411.84M | 372.83M | 341.40M | 315.40M | 303.11M | 323.13M | 269.94M |
| Gross Profit Ratio | 61.80% | 56.77% | 58.59% | 57.28% | 60.01% | 60.83% | 60.12% | 60.70% | 62.75% | 63.44% | 61.87% |
| Research & Development | 38.14M | 29.38M | 26.89M | 26.14M | 26.60M | 29.07M | 26.93M | 22.07M | 18.36M | 19.43M | 21.54M |
| General & Administrative | 66.89M | 72.53M | 74.14M | 77.67M | 74.35M | 62.82M | 58.07M | 58.10M | 49.75M | 49.65M | 49.48M |
| Selling & Marketing | 293.08M | 266.06M | 253.89M | 229.29M | 233.75M | 202.11M | 187.35M | 175.16M | 157.76M | 168.30M | 139.08M |
| SG&A | 359.97M | 293.43M | 298.55M | 280.35M | 277.41M | 260.75M | 234.13M | 216.88M | 207.51M | 217.95M | 188.56M |
| Other Expenses | 0.00 | -2.30M | 1.69M | -24.98M | -2.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 396.19M | 322.80M | 325.45M | 306.49M | 306.01M | 289.81M | 261.05M | 238.95M | 232.28M | 242.00M | 210.75M |
| Cost & Expenses | 698.22M | 633.51M | 623.05M | 575.44M | 580.44M | 529.86M | 487.47M | 443.12M | 412.21M | 428.23M | 377.08M |
| Interest Income | 3.45M | 779.00K | 168.00K | 459.00K | 1.02M | 3.40M | 2.83M | 2.10M | 2.30M | 3.30M | 3.90M |
| Interest Expense | 20.72M | 12.95M | 12.77M | 10.92M | 10.13M | 4.91M | 3.20M | 3.79M | 3.33M | 3.39M | 3.98M |
| Depreciation & Amortization | 49.92M | 49.37M | 51.53M | 48.13M | 43.56M | 24.15M | 22.52M | 21.65M | 15.37M | 15.09M | 12.66M |
| EBITDA | 143.25M | 134.51M | 147.15M | 102.19M | 149.38M | 107.16M | 95.00M | 94.97M | 92.61M | 100.84M | 72.50M |
| EBITDA Ratio | 18.23% | 18.72% | 20.48% | 16.23% | 21.77% | 17.49% | 18.12% | 18.88% | 19.17% | 19.80% | 16.62% |
| Operating Income | 87.46M | 85.14M | 95.62M | 54.07M | 105.83M | 83.02M | 80.35M | 76.45M | 77.24M | 85.75M | 59.84M |
| Operating Income Ratio | 11.13% | 11.85% | 13.31% | 8.59% | 15.42% | 13.55% | 14.15% | 14.71% | 15.99% | 16.84% | 13.72% |
| Total Other Income/Expenses | -14.85M | -28.97M | -9.38M | -41.35M | -7.26M | 2.88M | -6.08M | -2.49M | -8.72M | -7.92M | -4.56M |
| Income Before Tax | 72.61M | 55.82M | 86.24M | 12.43M | 90.01M | 93.40M | 68.49M | 69.53M | 68.52M | 77.83M | 55.29M |
| Income Before Tax Ratio | 9.24% | 7.77% | 12.00% | 1.97% | 13.12% | 15.24% | 12.06% | 13.38% | 14.19% | 15.28% | 12.67% |
| Income Tax Expense | 17.21M | 12.96M | 20.98M | 4.80M | 21.40M | 17.10M | 11.07M | 17.38M | 17.36M | 18.37M | 14.34M |
| Net Income | 58.39M | 42.51M | 63.99M | 6.21M | 66.04M | 79.75M | 57.56M | 50.91M | 51.24M | 59.45M | 40.48M |
| Net Income Ratio | 7.43% | 5.92% | 8.90% | 0.99% | 9.62% | 13.01% | 10.14% | 9.80% | 10.61% | 11.67% | 9.28% |
| EPS | 0.14 | 0.10 | 0.15 | 0.01 | 0.16 | 0.19 | 0.13 | 0.12 | 0.12 | 0.13 | 0.09 |
| EPS Diluted | 0.14 | 0.10 | 0.15 | 0.01 | 0.16 | 0.19 | 0.13 | 0.12 | 0.11 | 0.13 | 0.09 |
| Weighted Avg Shares Out | 420.30M | 417.76M | 422.16M | 421.78M | 423.38M | 425.66M | 430.64M | 439.26M | 445.59M | 453.79M | 449.85M |
| Weighted Avg Shares Out (Dil) | 420.32M | 417.83M | 422.80M | 422.73M | 424.57M | 426.48M | 432.45M | 440.68M | 445.66M | 452.71M | 449.85M |
Source: https://incomestatements.info
Category: Stock Reports